{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:21:02Z","timestamp":1760865662714},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s12519-011-0287-3","type":"journal-article","created":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T14:04:36Z","timestamp":1306937076000},"page":"224-231","source":"Crossref","is-referenced-by-count":14,"title":["Hereditary tyrosinemia type 1 from a single center in Egypt: clinical study of 22 cases"],"prefix":"10.1007","volume":"7","author":[{"given":"Hanaa","family":"El-Karaksy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"El-Raziky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nehal","family":"El-Koofy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rokaya","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed S.","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"El-Kiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"El-Hennawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"Mohsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,1]]},"reference":[{"key":"287_CR1","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/hmg\/2.7.941","volume":"2","author":"Y. Labelle","year":"1993","unstructured":"Labelle Y, Phaneuf D, Leclerc B, Tanguay RM. Characterization of the human fumarylacetoacetate hydrolase gene and identification of a missense mutation abolishing enzymatic activity. Hum Mol Genet 1993;2:941\u2013946.","journal-title":"Hum Mol Genet"},{"key":"287_CR2","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1073\/pnas.74.10.4641","volume":"74","author":"B. Lindblad","year":"1977","unstructured":"Lindblad B, Lindstedt S, Steen G. On the enzymic defects in hereditary tyrosinemia. Proc Natl Acad Sci USA 1977;74:4641\u20134645.","journal-title":"Proc Natl Acad Sci USA"},{"key":"287_CR3","first-page":"27","volume":"184","author":"E. Kvittingen","year":"1986","unstructured":"Kvittingen E. Hereditary tyrosinemia type I-an overview. Scand J Clin Lab Invest Suppl 1986;184:27\u201334.","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"287_CR4","first-page":"317","volume":"47","author":"P. Russo","year":"1990","unstructured":"Russo P, O\u2019Regan S. Visceral pathology of hereditary tyrosinemia type I. Am J Hum Genet 1990;47:317\u2013324.","journal-title":"Am J Hum Genet"},{"key":"287_CR5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0140-6736(92)92685-9","volume":"340","author":"S. Lindstedt","year":"1992","unstructured":"Lindstedt S, Holme E, Lock EA, Hjalmarson O, Strandvik B. Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 1992;340:813\u2013817.","journal-title":"Lancet"},{"key":"287_CR6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1089-3261(05)70142-2","volume":"4","author":"E. Holme","year":"2000","unstructured":"Holme E, Lindstedt S. Nontransplant treatment of tyrosinemia. Clin Liver Dis 2000;4:805\u2013814.","journal-title":"Clin Liver Dis"},{"key":"287_CR7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jchromb.2005.12.010","volume":"831","author":"O.Y. Al-Dirbashi","year":"2006","unstructured":"Al-Dirbashi OY, Rashed MS, Brink HJ, Jakobs C, Filimban N, Al-Ahaidib LY, et al. Determination of succinylacetone in dried blood spots and liquid urine as a dansylhydrazone by liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2006;831:274\u2013280.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"287_CR8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00431-009-1090-1","volume":"169","author":"H. El-Karaksy","year":"2010","unstructured":"El-Karaksy H, Rashed M, El-Sayed R, El-Raziky M, El-Koofy N, El-Hawary M, et al. NTBC Therapy for tyrosinemia type 1: how much is enough? Eur J Pediatr 2010;169:689\u2013693.","journal-title":"Eur J Pediatr"},{"key":"287_CR9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/jmg.20.1.58","volume":"20","author":"M. Hafez","year":"1983","unstructured":"Hafez M, El-Tahan H, Awadalla M, El-Khayat H, Abdel-Gafar A, Ghoneim M. Consanguineous matings in the Egyptian population. J Med Genet 1983;20:58\u201360.","journal-title":"J Med Genet"},{"key":"287_CR10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1023\/A:1014567800950","volume":"17","author":"M.M. Mokhtar","year":"2001","unstructured":"Mokhtar MM, Abdel-Fattah MM. Consanguinity and advanced maternal age as risk factors for reproductive losses in Alexandria, Egypt. Eur J Epidemiol 2001;17:559\u2013565.","journal-title":"Eur J Epidemiol"},{"key":"287_CR11","first-page":"302","volume":"47","author":"M. Braekeleer De","year":"1990","unstructured":"De Braekeleer M, Larochelle J. Genetic epidemiology of hereditary tyrosinemia in Quebec and in Saguenay-Lac-St-Jean. Am J Hum Genet 1990;47:302\u2013307.","journal-title":"Am J Hum Genet"},{"key":"287_CR12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1542\/peds.103.3.675","volume":"103","author":"J.M. Croffie","year":"1999","unstructured":"Croffie JM, Gupta SK, Chong SK, Fitzgerald JF. Tyrosinemia type 1 should be suspected in infants with severe coagulopathy even in the absence of other signs of liver failure. Pediatrics 1999;103:675\u2013678.","journal-title":"Pediatrics"},{"key":"287_CR13","first-page":"667","volume-title":"Liver Disease in Children","author":"G.A. Mitchell","year":"2001","unstructured":"Mitchell GA, Russo P, Dubois J, Alvarez F. Tyrosinemia. In: Suchy FJ, eds. Liver Disease in Children, 2nd ed. St. Louis: Mosby-Year Book, 2001:667\u2013686.","edition":"2nd ed."},{"key":"287_CR14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF01804389","volume":"14","author":"E.A. Kvittingen","year":"1991","unstructured":"Kvittingen EA, Talseth T, Halvorsen S, Jakobs C, Hovig T, Flatmark A. Renal failure in adult patients with hereditary tyrosinaemia type I. J Inherit Metab Dis 1991;14:53\u201362.","journal-title":"J Inherit Metab Dis"},{"key":"287_CR15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJM199002153220704","volume":"322","author":"G. Mitchell","year":"1990","unstructured":"Mitchell G, Larochelle J, Lambert M, Michaud J, Grenier A, Ogier H, et al. Neurologic crises in hereditary tyrosinemia. N Engl J Med 1990;322:432\u2013437.","journal-title":"N Engl J Med"},{"key":"287_CR16","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1096\/fasebj.13.15.2284","volume":"13","author":"R. Jorquera","year":"1999","unstructured":"Jorquera R, Tanguay RM. Cyclin B-dependent kinase and caspase-1 activation precedes mitochondrial dysfunction in fumarylacetoacetate-induced apoptosis. FASEB J 1999;13:2284\u20132298.","journal-title":"FASEB J"},{"key":"287_CR17","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/hmg\/10.17.1741","volume":"10","author":"R. Jorquera","year":"2001","unstructured":"Jorquera R, Tanguay RM. Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability. Hum Mol Genet 2001;10:1741\u20131752.","journal-title":"Hum Mol Genet"},{"key":"287_CR18","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0168-8278(03)00433-1","volume":"39","author":"M.C. Luijerink","year":"2003","unstructured":"Luijerink MC, Jacobs SM, van Beurden EA, Koornneef LP, Klomp LW, Berger R, et al. Extensive changes in liver gene expression induced by hereditary tyrosinemia type I are not normalized by treatment with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC). J Hepatol 2003;39:901\u2013909.","journal-title":"J Hepatol"},{"key":"287_CR19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2165\/00003495-200666060-00002","volume":"66","author":"P.J. McKiernan","year":"2006","unstructured":"McKiernan PJ. Nitisinone in the treatment of hereditary tyrosinaemia type 1. Drugs 2006;66:743\u2013750.","journal-title":"Drugs"},{"key":"287_CR20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1651-2227.2003.tb02518.x","volume":"92","author":"J. Crone","year":"2003","unstructured":"Crone J, Moslinger D, Bodamer OA, Schima W, Huber WD, Holme E, et al. Reversibility of cirrhotic regenerative liver nodules upon NTBC treatment in a child with tyrosinaemia type I. Acta Paediatr 2003;92:625\u2013628.","journal-title":"Acta Paediatr"},{"key":"287_CR21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00148581-200608010-00004","volume":"8","author":"M. Ashorn","year":"2006","unstructured":"Ashorn M, Pitkanen S, Salo MK, Heikinheimo M. Current strategies for the treatment of hereditary tyrosinemia type I. Pediatr Drugs 2006;8:47\u201354.","journal-title":"Pediatr Drugs"},{"key":"287_CR22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00005176-200501000-00017","volume":"40","author":"F.J. Spronsen van","year":"2005","unstructured":"van Spronsen FJ, Bijleveld CM, van Maldegem BT, Wijburg FA. Hepatocellular carcinoma in hereditary tyrosinemia type I despite 2-(2 nitro-4-3 trifluoro-methylbenzoyl)-1, 3-cyclohexanedione treatment. J Pediatr Gastroenterol Nutr 2005;40:90\u201393.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"287_CR23","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM198305263082105","volume":"308","author":"M.K. Hostetter","year":"1983","unstructured":"Hostetter MK, Levy HL, Winter HS, Knight GJ, Haddow JE. Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia. N Engl J Med 1983;308:1265\u20131267.","journal-title":"N Engl J Med"},{"key":"287_CR24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10545-008-0793-1","volume":"31","author":"A. Masurel-Paulet","year":"2008","unstructured":"Masurel-Paulet A, Poggi-Bach J, Rolland MO, Bernard O, Guffon N, Dobbelaere D, et al. NTBC treatment in tyrosinemia type I: long-term outcome in French patients. J Inherit Metab Dis 2008;31:81\u201387.","journal-title":"J Inherit Metab Dis"},{"key":"287_CR25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0730-725X(94)92354-X","volume":"12","author":"J. Liou","year":"1994","unstructured":"Liou J, Lee JKT, Borrello JA, Brown JJ. Differentiation of hepatomas from non-hepatomatous masses: use of MnDPDP enhanced MR images. Magn Res Imaging 1994;12:71\u201379.","journal-title":"Magn Res Imaging"},{"key":"287_CR26","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/BF03178035","volume":"26","author":"J. Dubois","year":"1996","unstructured":"Dubois J, Garel L, Patriquin H, Paradis K, Forget S, Filiatrault D, et al. Imaging features of type 1 hereditary tyrosinemia: a review of 30 patients. Pediatr Radiol 1996;26:845\u2013851.","journal-title":"Pediatr Radiol"},{"key":"287_CR27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s002470050551","volume":"29","author":"S. Forget","year":"1999","unstructured":"Forget S, Patriquin HB, Dubois J, Lafortune M, Merouani A, Paradis K, et al. The kidney in children with tyrosinaemia: sonographic, CT and biochemical findings. Pediatr Radiol 1999;29:104\u2013108.","journal-title":"Pediatr Radiol"},{"key":"287_CR28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10545-008-0817-x","volume":"31","author":"S. Santra","year":"2008","unstructured":"Santra S, Preece MA, Hulton SA, McKiernan PJ. Renal tubular function in children with tyrosinaemia type I treated with nitisinone. J Inherit Metab Dis 2008;31:399\u2013402.","journal-title":"J Inherit Metab Dis"},{"key":"287_CR29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1023\/A:1005462804271","volume":"21","author":"M. Grompe","year":"1998","unstructured":"Grompe M, Overturf K, Al-Dhalimy M, Finegold M. Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report. J Inher Metab Dis 1998;21:518\u2013531.","journal-title":"J Inher Metab Dis"},{"key":"287_CR30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/mgme.2001.3266","volume":"75","author":"M. Al-Dhalimy","year":"2002","unstructured":"Al-Dhalimy M, Overturf K, Finegold M, Grompe M. Longterm therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I. Mol Genet Metab 2002;75:38\u201345.","journal-title":"Mol Genet Metab"},{"key":"287_CR31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1023\/A:1005410820201","volume":"21","author":"E. Holme","year":"1998","unstructured":"Holme E, Lindstedt S. Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione). J Inherit Metab Dis 1998;21:507\u2013517.","journal-title":"J Inherit Metab Dis"},{"key":"287_CR32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00005176-200207000-00016","volume":"35","author":"H.M. Hanauske-Abel","year":"2002","unstructured":"Hanauske-Abel HM, Popowicz A, Remotti H, Newfield RS, Levy J. Tyrosinemia I, a model for human diseases mediated by 2-oxoacid-utilizing dioxygenases: hepatotoxin suppression by NTBC does not normalize hepatic collagen metabolism. J Pediatr Gastroenterol Nutr 2002;35:73\u201378.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"Suppl.2","key":"287_CR33","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1007\/PL00014321","volume":"158","author":"N. Mohan","year":"1999","unstructured":"Mohan N, McKiernan P, Preece MA, Green A, Buckels J, Mayer AD, et al. Indications and outcome of liver transplantation in tyrosinaemia type 1. Eur J Pediatr 1999;158Suppl. 2:S49\u201354.","journal-title":"Eur J Pediatr"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-011-0287-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-011-0287-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-011-0287-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T10:08:54Z","timestamp":1560247734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-011-0287-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,1]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["287"],"URL":"https:\/\/doi.org\/10.1007\/s12519-011-0287-3","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,1]]}}}